Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Public ClinicalTrials.gov record NCT03230864. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Study identification
- NCT ID
- NCT03230864
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- H. Lundbeck A/S
- Industry
- Enrollment
- 119 participants
Conditions and interventions
Conditions
Interventions
- Lu AF35700 Drug
- Risperidone Drug
- Olanzapine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 19, 2017
- Primary completion
- Dec 22, 2018
- Completion
- Feb 4, 2019
- Last update posted
- Jan 20, 2020
2017 – 2019
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California San Diego Health System | San Diego | California | 92103 | — |
| Emory University Cognitive Neurology Clinic & ADRC | Atlanta | Georgia | 30329 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Corrigan Mental Health Center | Fall River | Massachusetts | 02720 | — |
| University Of Massachusetts Medical Center | Worcester | Massachusetts | 01605-2610 | — |
| Michigan Clinical Research Institute PC | Ann Arbor | Michigan | 48108 | — |
| Kalamazoo Community Mental Health and Substance Abuse Services | Kalamazoo | Michigan | 49001 | — |
| PsychCare Consultants Research | St Louis | Missouri | 63128 | — |
| Creighton University | Omaha | Nebraska | 68131 | — |
| Psychiatric and Behavioral Solutions | Salt Lake City | Utah | 84105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03230864, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 20, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03230864 live on ClinicalTrials.gov.